High coverage with HAART is required to substantially reduce the number of deaths from tuberculosis: System dynamics simulation

International Journal of STD and AIDS

Volumn 18, Issue 4, 2007, Pages 267-273

  Atun, Rifat A ^a,e   Lebcir, Reda M ^b   Drobniewski, Francis ^c   McKee, Martin ^d   Coker, Richard J ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

HAART; HIV; Multidrug resistant tuberculosis; Russia; System dynamics; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; DEATH; DISEASE TRANSMISSION; DRUG SENSITIVITY; EPIDEMIC; HEALTH CARE POLICY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MIXED INFECTION; MORTALITY; OUTCOME ASSESSMENT; POPULATION; PRIORITY JOURNAL; SIMULATION; TUBERCULOSIS; AIDS RELATED COMPLEX; BIOLOGICAL MODEL; RUSSIAN FEDERATION; UTILIZATION REVIEW;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE TRANSMISSION, HORIZONTAL; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; RUSSIA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 34250679326     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646207780659024     Document Type: Article

References (39)

1. Vajpayee M, Kanswal S, Seth P, Wig N, Pandey RM. Tuberculosis infection in HIV infected Indian patients. AIDS Patient Care STDS 2004;18:209-13
2. Williams BG, Dye C. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science 2003;301:1535-7
3. Currie CSM, Williams BG, Cheng RCH, Dye C. Tuberculosis epidemics driven by HIV: is prevention better than cure? AIDS 2003;17:2501-8
4. Odhiambo JA, Borgdorff MW, Kiambih FM, et al. Tuberculosis and the HIV epidemics: increasing annual risk of tuberculosis infection in Kenya, 1986-1996. Am J Public Health 1999;89:1078-82
5. Coker RJ. Multidrug resistant tuberculosis: public health challenges. Trop Med Int Health 2004;9:25-40
6. De Cock K, Chaisson RE. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis 1999;3:457-65
7. Coetzee D, Hilderbrand K, Goemaere E, Matthys F, Boelaert M. Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health 2004;9:A11-15
8. Narain JP, Lo YR. Epidemiology of HIV-TB in Asia. Indian J Med Res 2004;120:277-90
9. Forrester JW. Industrial Dynamics. Cambridge, MA: The MIT Press, 1961
10. Richardson GP, Pugh AL. Introduction to System Dynamics with DYNAMO. Cambridge, MA: The MIT Press, 1981
11. Sterman JD. Business Dynamics. Systems Thinking and Modeling for a Complex World. Singapore: Mc-Graw Hill/Irwine, 2000
12. Atun RA, Lebcir RM, Drobniewski F, Coker RJ. Impact of an effective multidrug resistant tuberculosis control programme in the setting of an immature HIV epidemic: system dynamics simulation model'. Int J STD AIDS 2005;16:560-70
13. Atun RA, Lebcir RM, Coker RJ. Tuberculosis transmission in settings of high multidrug resistant tuberculosis and explosive epidemics of HIV: a system dynamics approach. Proceedings of the 22nd International Conference of the System Dynamics Society. Oxford, 2004
14. Dangerfield BC, Fang Y, Roberts CA. Model-based scenarios for the epidemiology of HIV/AIDS: the consequences of highly active antiretroviral therapy. Syst Dyn Rev 2001;17:119-50
15. DeAngelis D, Gilks WR, Day NE. Bayesian projection of the acquired immune deficiency syndrome epidemic. Appl Stat 1998;47:447-8
16. Homer JB, St Clair CL. A model of HIV transmission through needle sharing. Interfaces 1991;21:26-49
17. Centers for Disease Control and Prevention. Primary multidrug-resistant tuberculosis - Ivanovo Oblast, Russia, 1999. MMWR 1999;48:661-4
18. Mitnick C, Bayona J, Palacios E written contribution toet al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003;348:119-28
19. Tahaoglou K, Torun T, Sevim T, et al. The treatment of multidrug-resistant tuberculosis in Turkey. N Engl J Med 2001;345:170-4
20. World Health Organization and UNAIDS. WHO TB Control Report 2004. Global Tuberculosis Control - Surveillance, Planning, Financing WHO/HTM/TB/2004.331. Geneva: World Health Organization, 2004
21. Blower SM, Small PM, Hopewell P. Control strategies for tuberculosis epidemics: new models for old problems. Science 1996;273:497-500
22. Murray CLJ, Salomon JA. Modelling the impact of global tuberculosis control strategies. Proc Natl Acad Sci USA 1998;95:13881-6
23. Blower SM, Gerberding JL. Understanding, predicting, and controlling the emergence of drug-resistant tuberculosis: a theoretical framework. J Mol Med 1998;76:624-36
24. Vynnycky E, Fine PEM. Interpreting the decline in tuberculosis: the role of secular trends in effective contact. Int J Epidemiol 1999;28:327-34
25. Vynnycky E, Fine PEM. Lifetime risks, incubation period, and serial interval of tuberculosis. J Epidemiol 2000;152:247-63
26. Pitman R, Jarman B, Coker R. Tuberculosis transmission and the impact of intervention on the incidence of infection. Int J Tuberc Lung Dis 2002;6:485-91
27. Dye C, Williams BG. Criteria for the control of drug-resistant tuberculosis. Proc Natl Acad Sci USA 2000;97:8180-5
28. Pablos-Mendez A, Gowda DK, Frieden TR. Controlling multi-drug resistant tuberculosis and access to expensive drugs: a rational framework. Bull WHO 2002;80:489-95
29. Rhodes T, Lowndes C, Judd A, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russian Federation: implications for HIV prevention. AIDS 2002;16:F25-31
30. May RM, Anderson RM. The transmission dynamics of human immunodeficiency virus (HIV). Philos Trans R Soc Lond B Biol Sci 1988;321:565-607
31. Grassly N, Lowndes C, Rhodes T, Judd A, Renton A, Garnett GP. Modelling emerging HIV epidemics: the role of injection drug use and sexual transmission in the Russian Federation, China and India. Int J Drug Policy 2002;14:25-43
32. Dolan K, Wodak A, Hall W, Kaplan E. A mathematical model of HIV transmission in NSW prisons. Drug Alcohol Depend 1998;50:197-202
33. World Health Organization. Treating 3 Million by 2005: Making it Happen: the WHO Strategy: the WHO and UNAIDS Global Initiative to Provide Antiretroviral Therapy to 3 Million People with HIV/AIDS in Developing Countries by the End of 2005 Geneva: World Health Organization 2005
34. Sterman JD. Misperceptions of feedback in dynamic decision making. Organ Behav Hum Decis Process 1989a;43:301-35
35. Sterman JD. Modeling management behavior: misperception of feedback in a dynamic decision making experiment. Manag Sci 1989b;35:321-39
36. Homer J, Hirsch G, Minniti M, Pierson M. Models for collaboration: how system dynamics helped a community organize cost-effective care for chronic illness. Syst Dyn Rev 2004;20:199-222
37. Atun RA, McKee M, Drobniewski F, Coker R. Evaluating HIV control within a health systems context: case studies from the Russian Federation. Bull WHO 2005;83:730-8
38. Sterman JD. System dynamics modelling: tools for learning in a complex world. Calif Manage Rev 2001;43:8-25
39. Senge PM. The fifth discipline. The Art and Practice of the Learning Organization. New York: Doubleday, 1990